DARE - Daré Bioscience Inc. (DARE) CEO Sabrina Martucci Johnson on Q4 2021 Results - Earnings Call Transcript
Daré Bioscience, Inc. (DARE) Q4 2021 Earnings Conference Call March 31, 2022, 4:30 PM ET Company Participants Sabrina Martucci Johnson – President and Chief Executive Officer Lisa Walters-Hoffert – Chief Financial Officer John Fair – Chief Strategy Officer Conference Call Participants Zegbah Jallah – ROTH Capital Partners, LLC Douglas Tsao – H.C. Wainwright & Co. Kumaraguru Raja – Brookline Capital Markets Presentation Operator Welcome to the conference call hosted by Daré Bioscience to review the company's financial results for the year ended December 31, 2021, and to provide a general business update. This call is being recorded. My name is Catherine, and I'll be your Operator today. With us today are Sabrina Martucci Johnson, Dare's President and Chief Executive Officer, John Fair, Dare's Chief Strategy Officer, and Lisa Walters-Hoffert, Dare's Chief Financial Officer. Ms. Johnson, please proceed. Sabrina Martucci Johnson Thank you. Good afternoon, and welcome to our full-year 2021
For further details see:
Daré Bioscience, Inc. (DARE) CEO Sabrina Martucci Johnson on Q4 2021 Results - Earnings Call Transcript